Buprenorphine treatment produces improved outcome for babies born addicted

Dec 09, 2010

Babies born into the world addicted to drugs because of their mother's dependence on pain medication, or opioids, may be weaned off the substance more comfortably, with a shorter hospital stay and at a reduced cost, if the mother receives a new treatment option during pregnancy.

A study published Dec. 9, co-authored by Vanderbilt's Peter Martin, M.D., director of the Division of Addiction Psychiatry, found that the newer buprenorphine is at least as good for both mother and child as the standard care , when both were combined with comprehensive care treatment of opioid dependence in .

"The baby comes into the world addicted to what the mother was taking," Martin said.
"And everyone who comes in touch with these unfortunate realizes that they are very uncomfortable and incessantly restless.

"From this study we can say that both the mothers and the babies did equally well taking buprenorphine or methadone.

"However, we demonstrated a statistically significant improvement above the standard of care in important outcomes in the babies of mothers who received buprenorphine during the pregnancy compared to those who were administered methadone," he said.

The eight site, international, double-blind, double-dummy, flexible-dosing, randomized controlled trial is part of the MOTHER project, which stands for Maternal Opioid Treatment: Human Experimental Research.

Buprenorphine had previously not been well studied in pregnancy, although it is now widely prescribed to treat opioid addiction.

"It was only a matter of time before women who were receiving buprenorphine while they become pregnant were faced with the decision to continue it or change to methadone, the standard of care," Martin said.

"For this reason, it was considered very important to determine whether buprenorphine was at least as safe as methadone, so that doctors would know how to advise their patients."

Study results showed that babies of mothers who received compared to those who received methadone throughout pregnancy needed significantly less morphine to treat their neonatal abstinence syndrome, had shorter hospital stays (10 days vs. 17.5 days), and shorter duration of treatment for neonatal abstinence syndrome (4.1 days vs. 9.9. days).

The authors state that improved treatment options should reduce the public health and medical costs associated with the treatment of neonates exposed to opioids, estimated at $70.6 million to $112.6 million in 2009 in the United States.

Explore further: Loud talking and horseplay in car results in more serious incidents for teen drivers

add to favorites email to friend print save as pdf

Related Stories

Addicts helped by implanted devices: study

Oct 12, 2010

Persons addicted to heroin or prescription pain killers can get help kicking their habit by using an implanted device under the skin that delivers small doses of medication, researchers reported Tuesday.

Longer-lasting options to treat drug addiction

Oct 18, 2010

(AP) -- New treatments for addiction to heroin or narcotic painkillers promise longer-lasting relief that may remove some day-to-day uncertainty of care: A once-a-month shot is now approved and a six-month implant is in ...

Recommended for you

Obama: 8 million signed up for health care (Update)

13 hours ago

President Barack Obama said Thursday 8 million Americans have signed up for health care through new insurance exchanges, besting expectations and offering new hope to Democrats who are defending the law ahead ...

User comments : 0

More news stories

Leeches help save woman's ear after pit bull mauling

(HealthDay)—A pit bull attack in July 2013 left a 19-year-old woman with her left ear ripped from her head, leaving an open wound. After preserving the ear, the surgical team started with a reconnection ...

Scientists tether lionfish to Cayman reefs

Research done by U.S. scientists in the Cayman Islands suggests that native predators can be trained to gobble up invasive lionfish that colonize regional reefs and voraciously prey on juvenile marine creatures.

Venture investments jump to $9.5B in 1Q

Funding for U.S. startup companies soared 57 percent in the first quarter to a level not seen since 2001, as venture capitalists piled more money into an increasing number of deals, according to a report due out Friday.